Literature DB >> 22954118

Correlations of podocyte injury with glucose regulated protein 78 expression and proteinuria in patients with diabetic nephropathy.

Ying-jiu Liu1, Yu-bing Wen, Jian-ling Tao, Jin-hong Li, Ying Su, Wei Ye, Hang Li, Xue-mei Li, Xue-wang Li.   

Abstract

OBJECTIVE: To explore the podocyte injury in patients with diabetic nephropathy (DN) and analyze its relationship with glucose regulated protein 78 (GRP78) and proteinuria.
METHODS: The clinical data of 48 patients diagnosed as DN by renal biopsy were reviewed. All patients were divided into two groups according to proteinuria (>3.5 g/d, n=31 and 3.5 g/d, n=17). The density of podocytes was illustrated by immunohistochemistry staining of Wilms tumor-1 (WT-1), and the immunofluorescence double-staining results of synaptopodin and GRP78 in podocytes were detected.
RESULTS: The podocyte dentistry of urine protein > 3.5 g/d group was significantly lower than that of urine protein>3.5 g/d group urine protein<3.5 g/d group(P=0.003), and it was negatively correlated with proteinuria (P=0.005). The expressions of synaptopodin and GRP78 in podocytes were also negatively correlated with proteinuria (P=0.004 and P=0.001).
CONCLUSION: The podocyte injury is aggravated with increased proteinuria in DN patients, along with the decrease of the adaptive ability of endoplasmic reticulum to stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22954118     DOI: 10.3881/j.issn.1000-503X.2012.04.009

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  1 in total

1.  Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis.

Authors:  Yoshiko Hosoe-Nagai; Teruo Hidaka; Ayano Sonoda; Yu Sasaki; Kanae Yamamoto-Nonaka; Takuto Seki; Rin Asao; Eriko Tanaka; Juan Alejandro Oliva Trejo; Fumiko Kodama; Miyuki Takagi; Nobuhiro Tada; Takashi Ueno; Ryuichi Nishinakamura; Yasuhiko Tomino; Katsuhiko Asanuma
Journal:  Lab Invest       Date:  2017-07-31       Impact factor: 5.662

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.